FierceBiotech

FDA Approves Merck's GRASTEK® (Timothy Grass Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Grass Pollen-Induced Allergic Rhinitis with or without ...

WHITEHOUSE STATION, N.J.--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved GRASTEK® (Timothy Grass ...
Monthly Prescribing Reference

FDA Approves Timothy Grass Pollen SL Tab

FDA Approves Timothy Grass Pollen SL Tab Merck announced that the FDA has approved Grastek (Timothy grass pollen allergen extract) Tablet for Sublingual Use as immunotherapy for the treatment of grass ...
Medscape

FDA OKs Sublingual Grastek for Timothy Grass Pollen Allergy

The US Food and Drug Administration (FDA) has approved Timothy Grass Pollen Allergen Extract Tablet for Sublingual Use Grastek, Merck & Co, Inc) for the treatment of Timothy grass pollen-induced ...
Medscape

Grastek Recommended by FDA Panel for Timothy Grass Allergy

The Allergenic Products Committee of the US Food and Drug Administration (FDA) voted unanimously to recommend Timothy Grass Pollen Allergen Extract Tablet for Sublingual Use (MK-7243) (Grastek, Merck ...